Multiomics Market to Reach $8.06 Billion by 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Multiomics Market Be By 2030 Compared To Its 2026 Market Size?

The multiomics market size has seen rapid expansion in recent years. It is anticipated to increase from $3.85 billion in 2025 to $4.52 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.6%. This historical growth can be attributed to several factors, including the rise in genomic sequencing adoption, the early development of transcriptomics tools, the increased availability of proteomic analysis platforms, the expansion of biomarker identification research, and the growth in biological data generation.

The multiomics market is poised for significant expansion in the coming years, with its size projected to reach $8.07 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.6%. This anticipated growth during the forecast period stems from factors such as advancements in multiomics platforms, a rising need for personalized medicine, increased integration of AI-based analytics, the growing use of metabolomics in clinical settings, and the expanding applications of multiomics in precision agriculture. Major trends expected in this period include the increasing adoption of single-cell multiomics, the rising integration of multi-layer biological data, a greater use of multiomics in early disease diagnostics, the expansion of multiomics within drug discovery pipelines, and its growing application in agricultural genomics.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

What Significant Factors Are Influencing The Multiomics Market Expansion?

The multiomics market is projected to expand significantly due to the increasing demand for personalized medicine. Personalized medicine is a healthcare methodology that tailors treatment plans and decisions to individual patients, considering their specific genetic, environmental, and lifestyle factors. This approach is gaining traction driven by technological advancements, the escalating need for targeted therapies, and improvements across global healthcare. Multiomics facilitates personalized medicine by offering a detailed understanding of an individual’s genetic, molecular, and metabolic profile, enabling healthcare providers to customize treatments based on each patient’s unique characteristics. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a rise from 6 in 2022. Therefore, the growing demand for personalized medicine is a key driver for the multiomics market’s growth.

How Is Segmentation Applied In The Multiomics Market Segment Analysis?

The multiomics market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications

4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

What Trends Are Affecting The Direction Of The Multiomics Market?

Leading enterprises in the multiomics market are developing advanced single-cell multiomics platforms to enable scientists to conduct large-scale studies without compromising sample integrity. These platforms integrate diverse omics technologies with artificial intelligence capabilities, allowing users to effortlessly analyze and interpret complex biological data through sophisticated algorithms and machine learning techniques. For instance, in February 2023, Becton, Dickinson, and Company, a US-based medical device company, launched the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform. This innovative system empowers scientists to isolate, barcode, and analyze single cells at a high sample throughput, processing up to eight times more cells than previous versions of BD single-cell analyzers. The BD Rhapsody HT Xpress System ensures no sample loss, providing the flexibility to concurrently analyze multiple samples and different cell sizes and types, such as stem cells or cancer cells, thereby enhancing researchers’ ability to gain more insights in less time.

Who Are The Companies Participating In The Multiomics Market Environment?

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

Get The Full Multiomics Market Report:

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Which Region Dominates The Multiomics Market By Market Share?

North America was the largest region in the multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Multiomics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Browse Through More Reports Similar to the Global Multiomics Market 2026, By The Business Research Company

Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cancer Tumor Profiling Market Report

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Cancer Profiling Market Report

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795